• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SENP3 通过去 SUMO 化 STAT3 影响 PYCR1 的表达,从而促进膀胱癌的增殖和 EMT 转化。

SENP3 affects the expression of PYCR1 to promote bladder cancer proliferation and EMT transformation by deSUMOylation of STAT3.

机构信息

Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha City, Hunan Province 410005, China.

出版信息

Aging (Albany NY). 2022 Oct 11;14(19):8032-8045. doi: 10.18632/aging.204333.

DOI:10.18632/aging.204333
PMID:36227136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9596220/
Abstract

Abnormal activation of signal transducer and activator of transcription 3 (STAT3) has been found in various types of human cancers, including bladder cancer (BC). In our study, we examined the regulation of STAT3 post-translational modifications (PTMs) and found that SENP3 is high in bladder cancer. Sentrin/SUMO-specific protease3 (SENP3) and STAT3 were highly expressed in BC tissues when compared with tissue adjacent to carcinoma. SENP3 induced STAT3 protein level and p-STAT3 translocating into nuclear through deSUMOylation of STAT3. Further, nuclear STAT3, as a transcriptional activity factor, promoted pyrroline-5-carboxylate reductase 1 PYCR1 gene and protein level by interacting with the promoter of (PYCR1). Next, we found that knockdown of PYCR1 inhibited Epithelial to mesenchymal transition of bladder cancer, and simultaneously mitigated the carcinogenic effects of STAT3. , STAT3 knockdown in bladder cancer cells inhibited cell proliferation, migration, and invasion. In contrast, SENP3 overexpression reversed these effects. In all, results lend novel insights into the regulation of STAT3, which has key roles in bladder cancer progression.

摘要

信号转导子和转录激活子 3(STAT3)的异常激活已在包括膀胱癌(BC)在内的各种人类癌症中被发现。在我们的研究中,我们研究了 STAT3 翻译后修饰(PTM)的调节,发现 SENP3 在膀胱癌中高表达。与癌旁组织相比,SENP3 和 STAT3 在膀胱癌组织中高表达。SENP3 通过去 SUMO 化 STAT3 诱导 STAT3 蛋白水平和 p-STAT3 向核内转位。此外,核 STAT3 作为转录活性因子,通过与(PYCR1)启动子相互作用,促进吡咯啉-5-羧酸还原酶 1(PYCR1)基因和蛋白水平。接下来,我们发现敲低 PYCR1 抑制了膀胱癌的上皮间质转化,同时减轻了 STAT3 的致癌作用。在膀胱癌细胞中敲低 STAT3 抑制了细胞增殖、迁移和侵袭。相比之下,SENP3 的过表达逆转了这些效应。总之,这些结果为 STAT3 的调节提供了新的见解,STAT3 在膀胱癌的进展中具有关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/d463ac834488/aging-14-204333-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/59507e82b753/aging-14-204333-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/17fa5f0517b1/aging-14-204333-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/b07f8dcfdf18/aging-14-204333-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/de86e7a4cdd0/aging-14-204333-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/1f3d957b1ef3/aging-14-204333-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/fdbb0aaacfe2/aging-14-204333-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/d463ac834488/aging-14-204333-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/59507e82b753/aging-14-204333-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/17fa5f0517b1/aging-14-204333-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/b07f8dcfdf18/aging-14-204333-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/de86e7a4cdd0/aging-14-204333-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/1f3d957b1ef3/aging-14-204333-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/fdbb0aaacfe2/aging-14-204333-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e4/9596220/d463ac834488/aging-14-204333-g007.jpg

相似文献

1
SENP3 affects the expression of PYCR1 to promote bladder cancer proliferation and EMT transformation by deSUMOylation of STAT3.SENP3 通过去 SUMO 化 STAT3 影响 PYCR1 的表达,从而促进膀胱癌的增殖和 EMT 转化。
Aging (Albany NY). 2022 Oct 11;14(19):8032-8045. doi: 10.18632/aging.204333.
2
SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer.SUMO化修饰和SENP3调节头颈癌中的STAT3激活。
Oncogene. 2016 Nov 10;35(45):5826-5838. doi: 10.1038/onc.2016.124. Epub 2016 May 16.
3
Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.敲低 PYCR1 通过调控 STAT3 介导的 p38 MAPK 和 NF-κB 信号通路抑制结直肠癌细胞的增殖、耐药和 EMT。
Biochem Biophys Res Commun. 2019 Dec 3;520(2):486-491. doi: 10.1016/j.bbrc.2019.10.059. Epub 2019 Oct 10.
4
SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.SENP2通过去SUMO化修饰转化生长因子-β受体I(TGF-βRI)抑制膀胱癌细胞的上皮-间质转化。
Mol Carcinog. 2017 Oct;56(10):2332-2341. doi: 10.1002/mc.22687. Epub 2017 Jun 30.
5
Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.星形胶质细胞上调基因1通过激活信号转导和转录激活因子3促进膀胱癌细胞的侵袭和上皮-间质转化。
Int J Urol. 2018 Feb;25(2):157-163. doi: 10.1111/iju.13486. Epub 2017 Nov 8.
6
HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27.HMGN5 通过与热休克蛋白 27 相互作用促进 IL-6 诱导的膀胱癌上皮-间充质转化。
Aging (Albany NY). 2020 Apr 21;12(8):7282-7298. doi: 10.18632/aging.103076.
7
SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.SENP3通过拮抗SUMO2/3靶向的泛素化和降解来调节整体蛋白质周转和Sp1水平。
Protein Cell. 2016 Jan;7(1):63-77. doi: 10.1007/s13238-015-0216-7. Epub 2015 Oct 28.
8
EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo.EIF5A2 可预测局部浸润性膀胱癌的预后,并在体外和体内促进膀胱癌的侵袭性。
Br J Cancer. 2014 Apr 2;110(7):1767-77. doi: 10.1038/bjc.2014.52. Epub 2014 Feb 6.
9
Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.白细胞介素-6/信号转导与转录激活因子3反式激活异常表达的Fra-1通过上皮-间质转化促进结直肠癌侵袭性。
Carcinogenesis. 2015 Apr;36(4):459-68. doi: 10.1093/carcin/bgv017. Epub 2015 Mar 6.
10
Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.丹参酮IIA通过调节STAT3-CCL2信号通路抑制膀胱癌细胞的上皮-间质转化
Int J Mol Sci. 2017 Jul 25;18(8):1616. doi: 10.3390/ijms18081616.

引用本文的文献

1
The key enzyme PYCR1 in proline metabolism: a dual driver of cancer progression and fibrotic remodeling.脯氨酸代谢中的关键酶PYCR1:癌症进展和纤维化重塑的双重驱动因素
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2545620. doi: 10.1080/14756366.2025.2545620. Epub 2025 Sep 2.
2
Effect and mechanism of PYCR1 on biological function of hepatocellular carcinoma cells under hypoxia.缺氧条件下PYCR1对肝癌细胞生物学功能的影响及机制
Discov Oncol. 2025 Jun 20;16(1):1167. doi: 10.1007/s12672-025-03028-7.
3
Crosstalk between SUMOylation and ubiquitination controls the stability of transcription factor zinc finger protein 24: a novel antitumor mechanism in bladder cancer.

本文引用的文献

1
SENP Proteases as Potential Targets for Cancer Therapy.小泛素样修饰蛋白特异性蛋白酶作为癌症治疗的潜在靶点
Cancers (Basel). 2021 Apr 24;13(9):2059. doi: 10.3390/cancers13092059.
2
PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling.PYCR1 通过影响 Akt/Wnt/β-连环蛋白信号通路促进膀胱癌。
J Bioenerg Biomembr. 2021 Apr;53(2):247-258. doi: 10.1007/s10863-021-09887-3. Epub 2021 Mar 10.
3
SUMO is a pervasive regulator of meiosis.SUMO 是一种普遍存在的减数分裂调节因子。
SUMO化与泛素化之间的相互作用调控转录因子锌指蛋白24的稳定性:膀胱癌中的一种新型抗肿瘤机制
Oncogene. 2025 May 28. doi: 10.1038/s41388-025-03450-9.
4
Mechanism of SMYD2 promoting stemness maintenance of bladder cancer stem cells by regulating PYCR1 expression and PINK1/Parkin mitophagy pathway.SMYD2通过调节PYCR1表达及PINK1/Parkin线粒体自噬途径促进膀胱癌干细胞干性维持的机制
Int J Oncol. 2025 May;66(5). doi: 10.3892/ijo.2025.5747. Epub 2025 May 9.
5
SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration.SENP3介导SIX1的去SUMO化修饰以促进前列腺癌的增殖和迁移。
Cell Mol Biol Lett. 2024 Dec 2;29(1):146. doi: 10.1186/s11658-024-00665-8.
6
ITPKA phosphorylates PYCR1 and promotes the progression of glioma.ITPKA使PYCR1磷酸化并促进胶质瘤进展。
Heliyon. 2024 Jul 30;10(15):e35303. doi: 10.1016/j.heliyon.2024.e35303. eCollection 2024 Aug 15.
7
Screening a knowledge-based library of low molecular weight compounds against the proline biosynthetic enzyme 1-pyrroline-5-carboxylate 1 (PYCR1).针对脯氨酸生物合成酶 1-吡咯啉-5-羧酸 1(PYCR1)筛选基于知识的小分子化合物文库。
Protein Sci. 2024 Jul;33(7):e5072. doi: 10.1002/pro.5072.
8
Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography.基于对接引导的 X 射线晶体学研究新型 PYCR1 片段抑制剂
J Chem Inf Model. 2024 Mar 11;64(5):1704-1718. doi: 10.1021/acs.jcim.3c01879. Epub 2024 Feb 27.
9
SENP3 mediates the activation of the Wnt/β-catenin signaling pathway to accelerate the growth and metastasis of oesophagal squamous cell carcinoma in mice.SENP3 介导 Wnt/β-连环蛋白信号通路的激活,从而加速小鼠食管鳞癌的生长和转移。
Funct Integr Genomics. 2024 Feb 22;24(2):40. doi: 10.1007/s10142-024-01321-2.
10
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance.解析 STAT3 信号通路在肝细胞癌中的作用:肿瘤发生、治疗耐药及药理学意义。
Cell Mol Biol Lett. 2023 Apr 21;28(1):33. doi: 10.1186/s11658-023-00438-9.
Elife. 2021 Jan 27;10:e57720. doi: 10.7554/eLife.57720.
4
Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.USP18/FTO/PYCR1 信号网络失调促进膀胱癌发生和进展。
Aging (Albany NY). 2021 Jan 10;13(3):3909-3925. doi: 10.18632/aging.202359.
5
STAT3 and its targeting inhibitors in osteosarcoma.STAT3 及其在骨肉瘤中的靶向抑制剂。
Cell Prolif. 2021 Feb;54(2):e12974. doi: 10.1111/cpr.12974. Epub 2020 Dec 31.
6
Melatonin derivatives combat with inflammation-related cancer by targeting the Main Culprit STAT3.褪黑素衍生物通过靶向主要罪魁祸首 STAT3 来对抗与炎症相关的癌症。
Eur J Med Chem. 2021 Feb 5;211:113027. doi: 10.1016/j.ejmech.2020.113027. Epub 2020 Nov 17.
7
The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications.小泛素样修饰特异性蛋白酶SENP3在人类疾病中的关键作用及临床意义
Front Physiol. 2020 Oct 30;11:558220. doi: 10.3389/fphys.2020.558220. eCollection 2020.
8
screening for proline analog inhibitors of the proline cycle enzyme PYCR1.筛选脯氨酸循环酶 PYCR1 的脯氨酸类似物抑制剂。
J Biol Chem. 2020 Dec 25;295(52):18316-18327. doi: 10.1074/jbc.RA120.016106. Epub 2020 Oct 27.
9
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.膀胱癌的尿生物标志物:当前研究现状及未来方向综述。
Urol Oncol. 2021 Jan;39(1):41-51. doi: 10.1016/j.urolonc.2020.08.016. Epub 2020 Sep 9.
10
SUMO: From Bench to Bedside.SUMO:从基础到临床。
Physiol Rev. 2020 Oct 1;100(4):1599-1619. doi: 10.1152/physrev.00025.2019.